• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质基质细胞及其归巢能力在椎间盘再生中的应用。

The Application of Mesenchymal Stromal Cells and Their Homing Capabilities to Regenerate the Intervertebral Disc.

机构信息

Tissue Engineering for Orthopaedics & Mechanobiology (TOM), The Department for BioMedical Research (DBMR) of the Faculty of Medicine of the University of Bern, University of Bern, CH-3008 Bern, Switzerland.

Department of Orthopaedics, Emory University School of Medicine, VAMC, 1670 Clairmont Rd, Decatur, GA 30033, USA.

出版信息

Int J Mol Sci. 2021 Mar 29;22(7):3519. doi: 10.3390/ijms22073519.

DOI:10.3390/ijms22073519
PMID:33805356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036861/
Abstract

Chronic low back pain (LBP) remains a challenging condition to treat, and especially to cure. If conservative treatment approaches fail, the current "gold standard" for intervertebral disc degeneration (IDD)-provoked back pain is spinal fusion. However, due to its invasive and destructive nature, the focus of orthopedic research related to the intervertebral disc (IVD) has shifted more towards cell-based therapeutic approaches. They aim to reduce or even reverse the degenerative cascade by mimicking the human body's physiological healing system. The implementation of progenitor and/or stem cells and, in particular, the delivery of mesenchymal stromal cells (MSCs) has revealed significant potential to cure the degenerated/injured IVD. Over the past decade, many research groups have invested efforts to find ways to utilize these cells as efficiently and sustainably as possible. This narrative literature review presents a summary of achievements made with the application of MSCs for the regeneration of the IVD in recent years, including their preclinical and clinical applications. Moreover, this review presents state-of-the-art strategies on how the homing capabilities of MSCs can be utilized to repair damaged or degenerated IVDs, as well as their current limitations and future perspectives.

摘要

慢性下腰痛(LBP)仍然是一种具有挑战性的治疗疾病,尤其是治愈。如果保守治疗方法失败,目前治疗椎间盘退变(IDD)引起的腰痛的“金标准”是脊柱融合术。然而,由于其具有侵袭性和破坏性,与椎间盘(IVD)相关的骨科研究的重点更多地转向了基于细胞的治疗方法。它们旨在通过模拟人体的生理愈合系统来减少甚至逆转退行性级联反应。祖细胞和/或干细胞的应用,特别是间充质基质细胞(MSC)的输送,已经显示出了治愈退化/受伤的 IVD 的巨大潜力。在过去的十年中,许多研究小组已经努力寻找尽可能高效和可持续地利用这些细胞的方法。本综述性文献总结了近年来应用 MSC 促进 IVD 再生的研究进展,包括其临床前和临床应用。此外,本综述还介绍了如何利用 MSC 的归巢能力修复受损或退化的 IVD 的最新策略,以及它们目前的局限性和未来的展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/eab436df6b50/ijms-22-03519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/95ce74933248/ijms-22-03519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/4bbaa8cca9e6/ijms-22-03519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/eab436df6b50/ijms-22-03519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/95ce74933248/ijms-22-03519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/4bbaa8cca9e6/ijms-22-03519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/8036861/eab436df6b50/ijms-22-03519-g003.jpg

相似文献

1
The Application of Mesenchymal Stromal Cells and Their Homing Capabilities to Regenerate the Intervertebral Disc.间质基质细胞及其归巢能力在椎间盘再生中的应用。
Int J Mol Sci. 2021 Mar 29;22(7):3519. doi: 10.3390/ijms22073519.
2
The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc.基于间充质干细胞的椎间盘再生的微环境影响。
Spine J. 2013 Mar;13(3):352-62. doi: 10.1016/j.spinee.2012.12.005. Epub 2013 Jan 20.
3
Human umbilical cord-derived mesenchymal stem cells and their chondroprogenitor derivatives reduced pain and inflammation signaling and promote regeneration in a rat intervertebral disc degeneration model.人脐带间充质干细胞及其软骨前体细胞衍生物可减少大鼠椎间盘退变模型中的疼痛和炎症信号传导,并促进其再生。
Mol Cell Biochem. 2021 Aug;476(8):3191-3205. doi: 10.1007/s11010-021-04155-9. Epub 2021 Apr 17.
4
Human umbilical cord derivatives regenerate intervertebral disc.人脐带衍生细胞可修复椎间盘。
J Tissue Eng Regen Med. 2018 Jan;12(1):e579-e591. doi: 10.1002/term.2330. Epub 2017 Mar 22.
5
Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc.生长分化因子-5有助于椎间盘的结构和功能维持。
Cell Physiol Biochem. 2015;35(1):1-16. doi: 10.1159/000369670. Epub 2015 Jan 2.
6
Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration.多能干细胞向椎间盘再生的髓核祖细胞分化
Curr Stem Cell Res Ther. 2019;14(1):57-64. doi: 10.2174/1574888X13666180918095121.
7
Mesenchymal stem cells for intervertebral disc regeneration.间质干细胞在椎间盘再生中的应用。
J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4 Suppl 1):173-179.
8
Intervertebral disc regeneration with an adipose mesenchymal stem cell-derived tissue-engineered construct in a rat nucleotomy model.脂肪间充质干细胞衍生的组织工程构建物在大鼠核切模型中对椎间盘的再生作用。
Acta Biomater. 2019 Mar 15;87:118-129. doi: 10.1016/j.actbio.2019.01.050. Epub 2019 Jan 25.
9
Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration: a preliminary study on biglycan-deficient murine model of chronic disc degeneration.人脂肪间充质基质细胞在椎间盘再生中的潜在应用:对核心蛋白聚糖缺陷型慢性椎间盘退变小鼠模型的初步研究
Arthritis Res Ther. 2014 Oct 8;16(5):457. doi: 10.1186/s13075-014-0457-5.
10
The Traceability of Mesenchymal Stromal Cells After Injection Into Degenerated Discs in Patients with Low Back Pain.注射到腰痛患者退变椎间盘后的间充质基质细胞的溯源性。
Stem Cells Dev. 2019 Sep 1;28(17):1203-1211. doi: 10.1089/scd.2019.0074. Epub 2019 Jul 23.

引用本文的文献

1
Harnessing CRISPR potential for intervertebral disc regeneration strategies.利用CRISPR技术在椎间盘再生策略中的潜力。
Front Bioeng Biotechnol. 2025 May 8;13:1562412. doi: 10.3389/fbioe.2025.1562412. eCollection 2025.
2
Advancements in Degenerative Disc Disease Treatment: A Regenerative Medicine Approach.退行性椎间盘疾病治疗的进展:一种再生医学方法。
Stem Cell Rev Rep. 2025 Apr 15. doi: 10.1007/s12015-025-10882-z.
3
Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles.创新椎间盘退变治疗方法:利用细胞外囊泡的力量

本文引用的文献

1
A 3D-Bioprinted dual growth factor-releasing intervertebral disc scaffold induces nucleus pulposus and annulus fibrosus reconstruction.一种3D生物打印的双生长因子释放椎间盘支架可诱导髓核和纤维环重建。
Bioact Mater. 2020 Aug 14;6(1):179-190. doi: 10.1016/j.bioactmat.2020.06.022. eCollection 2021 Jan.
2
Interaction between Mesenchymal Stem Cells and Intervertebral Disc Microenvironment: From Cell Therapy to Tissue Engineering.间充质干细胞与椎间盘微环境之间的相互作用:从细胞治疗到组织工程
Stem Cells Int. 2019 Sep 10;2019:2376172. doi: 10.1155/2019/2376172. eCollection 2019.
3
Combined Hydrogel and Mesenchymal Stem Cell Therapy for Moderate-Severity Disc Degeneration in Goats.
J Orthop Translat. 2025 Jan 7;50:44-55. doi: 10.1016/j.jot.2024.09.014. eCollection 2025 Jan.
4
High impact works on stem cell transplantation in intervertebral disc degeneration.关于干细胞移植治疗椎间盘退变的高影响力研究。
BMC Musculoskelet Disord. 2024 Dec 19;25(1):1029. doi: 10.1186/s12891-024-08131-4.
5
Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters.评估来自年轻和老年患者来源的 Tie2 再生活体细胞移植,结果表明年龄仍然很重要。
Int J Mol Sci. 2024 Jul 30;25(15):8335. doi: 10.3390/ijms25158335.
6
Diverse and multifunctional roles for perlecan () in repair of the intervertebral disc.基底膜聚糖()在椎间盘修复中的多样且多功能作用。
JOR Spine. 2024 Jul 29;7(3):e1362. doi: 10.1002/jsp2.1362. eCollection 2024 Sep.
7
Getting to the Core: Exploring the Embryonic Development from Notochord to Nucleus Pulposus.深入核心:探索从脊索到髓核的胚胎发育过程。
J Dev Biol. 2024 Jul 3;12(3):18. doi: 10.3390/jdb12030018.
8
Image-Guided Minimally Invasive Treatment Options for Degenerative Lumbar Spine Disease: A Practical Overview of Current Possibilities.影像引导下退行性腰椎疾病的微创治疗选择:当前可能性的实用概述
Diagnostics (Basel). 2024 May 30;14(11):1147. doi: 10.3390/diagnostics14111147.
9
Transcriptomic profiling reveals key early response genes during GDF6-mediated differentiation of human adipose-derived stem cells to nucleus pulposus cells.转录组分析揭示了在生长分化因子6介导的人脂肪来源干细胞向髓核细胞分化过程中的关键早期反应基因。
JOR Spine. 2024 Jan 19;7(1):e1315. doi: 10.1002/jsp2.1315. eCollection 2024 Mar.
10
Interventional Therapy and Surgical Management of Lumbar Disc Herniation in Spine Surgery: A Narrative Review.脊柱外科中腰椎间盘突出症的介入治疗与手术管理:一项叙述性综述
Orthop Rev (Pavia). 2023 Nov 22;15:88931. doi: 10.52965/001c.88931. eCollection 2023.
水凝胶联合间充质干细胞治疗山羊中重度椎间盘退变。
Tissue Eng Part A. 2021 Jan;27(1-2):117-128. doi: 10.1089/ten.TEA.2020.0103. Epub 2020 Aug 7.
4
Therapeutic Potential of Extracellular Vesicles in Degenerative Diseases of the Intervertebral Disc.细胞外囊泡在椎间盘退行性疾病中的治疗潜力
Front Bioeng Biotechnol. 2020 Apr 17;8:311. doi: 10.3389/fbioe.2020.00311. eCollection 2020.
5
Pathomechanism of intervertebral disc degeneration.椎间盘退变的发病机制。
JOR Spine. 2020 Feb 13;3(1):e1076. doi: 10.1002/jsp2.1076. eCollection 2020 Mar.
6
The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment.椎间盘的免疫特权:对椎间盘退变治疗的影响。
Int J Med Sci. 2020 Feb 24;17(5):685-692. doi: 10.7150/ijms.42238. eCollection 2020.
7
Mesenchymal Stem Cell Homing Into Intervertebral Discs Enhances the Tie2-positive Progenitor Cell Population, Prevents Cell Death, and Induces a Proliferative Response.间质干细胞归巢至椎间盘可增强 Tie2 阳性祖细胞群体,防止细胞死亡,并诱导增殖反应。
Spine (Phila Pa 1976). 2019 Dec 1;44(23):1613-1622. doi: 10.1097/BRS.0000000000003150.
8
Therapeutic potential of growth differentiation factors in the treatment of degenerative disc diseases.生长分化因子在退行性椎间盘疾病治疗中的治疗潜力。
JOR Spine. 2019 Mar 8;2(1):e1045. doi: 10.1002/jsp2.1045. eCollection 2019 Mar.
9
Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells?再生医学中的争议:椎间盘退变是否应由间充质干细胞治疗?
JOR Spine. 2019 Mar 1;2(1):e1043. doi: 10.1002/jsp2.1043. eCollection 2019 Mar.
10
Application of Cytokines of the Bone Morphogenetic Protein (BMP) Family in Spinal Fusion - Effects on the Bone, Intervertebral Disc and Mesenchymal Stromal Cells.骨形态发生蛋白(BMP)家族细胞因子在脊柱融合中的应用——对骨、椎间盘和间充质基质细胞的影响
Curr Stem Cell Res Ther. 2019;14(8):618-643. doi: 10.2174/1574888X14666190628103528.